NURS FPX 4055 Assessment 4: Health Promotion Plan Presentation
Greetings to all, and welcome to this session on health promotion. Teenagers and young adults in Schwenksville, Pennsylvania, between the ages of 11 and 26, are our target demographic to avoid HPV. An overview of HPV, its link to specific malignant illnesses, the benefits of early HPV vaccination, and how to effectively communicate the HPV vaccine to family members and healthcare providers is covered in this NURS FPX 4055 Assessment 4. To guarantee a generally targeted outcome character, the session is guided by SMART goals that are in line with Healthy People 2030 objectives.
Presentation Overview
The health promotion plan presentation covers the basic information regarding HPV, including how it is spread and how it is linked to various malignancies. After that, we will talk about the effectiveness and safety of the HPV vaccine and encourage participants to think about getting it within the following 30 days. Gaining the confidence to discuss the vaccine with family members and medical professionals is another top objective. As stated in NURS FPX 4055 Assessment 4, interactive exercises will reinforce the material, and a post-presentation exam and survey will be used to gauge durability.
Key Facts About HPV and Cancer Risk
Health promotion plans examples can be used to address HPV, a common virus that is mostly transmitted through sexual contact and skin-to-skin contact. Adolescents in Pennsylvania are still only 68.7% fully vaccinated against HPV, with the lowest rates occurring in the rural community of Schwenksville (48.7%) (PA.gov, 2025). Cervical, oropharyngeal, anal, and vaginal cancers are among the many cancers that HPV is a major cause of. The body is unable to identify high-risk strains, such as HPV 16 and 18, which eventually cause cell abnormalities and cancer. While the majority of illnesses are thought to be curable without treatment, some still cause
Benefits of Timely HPV Vaccination
As stressed in the health promotion plan presentation, it is best to vaccinate against the HPV virus when the child is 11 or 12 years old, as this allows the immune system to develop robust and long-lasting protection prior to potential exposure. This is a schedule that maximizes the transmission of vaccinations to prevent HPV-based diseases (Hoes et al., 2021). By getting immunized in time, cervical cancer, which is one of the most prevalent diseases in women across the world, and penile, anal, and oral cancers can all be reduced significantly (Cheng et al., 2020). Moreover, according to NURS FPX 4055 Assessment 4, with the help of the vaccine, the stigma and the emotional vaginal pain disappear because the ulcers in the genital area are eradicated. Moreover, early vaccination reduces the spread of the virus and protects vulnerable people by supporting herd immunity in general (Xu et al., 2024).
Communication Strategies for HPV Vaccination
Health promotion plan examples should include evidence-based and inclusive communication regarding HPV vaccination. Credible sources, like the CDC and WHO, should be used to communicate the facts about the safety and efficacy of vaccines. It is recommended to develop a discussion and ask informed questions about the long-term benefits of the vaccine (Kassymbekova et al., 2023). Eliminating misunderstandings is also crucial. For example, NURS FPX 4055 Assessment 4 discusses how getting an HPV vaccination helps prevent sickness rather than promote early sexual engagement.
SMART Goals for the Session
- Knowledge: According to a post-session test, at least 90% of participants will be able to correctly identify three facts about HPV and its link to cancer.
- Commitment: The participant agrees to set up the initial HPV vaccination dosage within 30 days.
3. Confidence: At least 85% of respondents report feeling more comfortable discussing the immunization with family members and healthcare professionals.
To improve relationship building, the next sessions can incorporate role plays and family participation.
Evaluation of SMART Goal Outcomes
Two SMART goals were accomplished. Since 92.5 percent of survey participants said they could name at least three accurate facts concerning HPV, the knowledge aim was satisfactorily met. Since 85% of participants found it easier to discuss the vaccine, the confidence measure was met. Only 75% of respondents said they would schedule the jab, which is a little less than the 80% threshold. Reluctance to cope with vaccine myths is a significant factor in NURS FPX 4055 Assessment 4, as some participants expressed a desire to consult the family before making a decision. Role-playing can be used to enhance communication skills during follow-up visits as part of family treatment.
Alignment With Healthy People 2030 Objectives
“This session will demonstrate health promotion ideas for communities and contribute to the Healthy People 2030 target of raising teenage HPV vaccination rates. The initiative promoted health prevention, raised awareness, and enhanced knowledge about immunizations. Even though vaccination commitment fell short of the goal, the progress indicates that the tactics are effective; yet, they still require more improvement to overcome hesitation. As stressed in
Conclusion
As covered in NURS FPX 4055 Assessment 4, this health promotion session was significant because it emphasized the value of early HPV vaccination in preventing cancer and safeguarding the lives of residents in the Schwenksville area. The health promotion plan presentation emphasized that although the program was successful in educating and boosting confidence, there were indications that it needed to be modified further, namely in terms of vaccine commitment. The development of a healthy generation of adolescents and young adults, as well as the community’s progress toward the Healthy People 2030 goals, can be aided by evidence-based practices and community involvement.
Summary Table
| Key Focus Area | Details | Impact/Outcome |
| HPV Facts & Risks | Sexually transmitted infections like HPV are linked to genital, throat, anal, and cervical cancers. Vaccination rates are low in rural regions like Schwenksville (48.7%). | Early identification and vaccination helped to prevent HPV and lower the incidence of cancer. |
| Vaccination Benefits | Early vaccination (ages 11–12) results in a stronger immune response and protects against genital warts and several types of cancer (Hoes et al., 2021; Cheng et al., 2020). | Reduces risk for individuals and society in favor of population health. |
| Communication & SMART Goals | Informational facts, well-informed questions, and debunking myths (Kassymbekova et al., 2023). Gaining knowledge, dedication, and communication confidence were the goals. | Knowledge (92.5%) and confidence (85) goals were met; vaccine commitment (75%) fell short of expectations; further improvements will be made. |
References
Cheng, L., Wang, Y., & Du, J. (2020). Human papillomavirus vaccines: An updated review. Vaccines, 8(3), 391. https://doi.org/10.3390/vaccines8030391
Hoes, J., Pasmans, H., Schurink-van ’t Klooster, T. M., van der Klis, F. R. M., Donken, R., Berkhof, J., & de Melker, H. E. (2021). Review of long-term immunogenicity following HPV vaccination: Gaps in current knowledge. Human Vaccines & Immunotherapeutics, 18(1). https://doi.org/10.1080/21645515.2021.1908059
Huber, J., Mueller, A., Sailer, M., & Regidor, P.-A. (2021). Human papillomavirus persistence or clearance after infection in reproductive age: What is the status? Review of the literature and new data of a vaginal gel containing silicate dioxide, citric acid, and selenite. Women’s Health, 17. https://doi.org/10.1177/17455065211028996
Kassymbekova, K., Abdukhakimova, A., Zhakipbekova, B., & Kurmangaliyev, A. (2023). Communication approaches in vaccination promotion. Health Promotion International, 38(1). https://doi.org/10.1093/heapro/daac112
U.S. Department of Health and Human Services. (n.d.). HPV vaccination: Healthy People 2030. https://health.gov/healthypeople/objectives-and-data/browse-objectives/vaccination/incr ease-hpv-vaccine-rates
Xu, Y., Liang, S., & Zhao, Q. (2024). Community herd immunity and HPV: Modeling impacts of adolescent vaccination. Public Health Reports, 139(2), 215–223. https://doi.org/10.1177/00333549231102378





